Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Health Care M+A Weekly Deals, The Week Ending October 6, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price D’Amore Healthcare, Inc. Pat Moore Foundation N/A Biotechnology Acquirer Target Price Gesynta Pharma AB Rights to OX-MPI program N/A BlueRock... Read More »
Stat of the Week: September 2017 Deal Volume
It was business as usual for healthcare deal makers in September 2017. The 118 transactions we’ve captured to this point are 9% ahead of August’s deal volume (108 deals), but down 13% compared with the same month in 2016 (135 deals). If you’ve read this column at all in 2017, you’re not surprised. The market is still transitioning toward value-based care and reimbursement, and that’s boosted a couple of sectors, and given others pause. One sector that’s seen deal volume wax over the past 18 months is Physician Medical Groups. Only six transactions surfaced in September 2017 (-33% vs. August, and -50% from a year ago), but the deals aren’t over yet. Private physician practices still face... Read More »Health Care M&A Weekly Deals, The Week Ending September 29, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price TRPharm License to FP-001 program N/A Geom Therapeutics, Inc. License to BLI program N/A Casebia Therapeutics Collaboration on gene-edited Tregs N/A Home Health Care & Hospice... Read More »
Stat(s) of the Week: 2017 Deal Volume Change, by Sector
If you thought 2017 has been slow for mergers and acquisitions, you must focus on the Home Health & Hospice or Pharmaceutical sectors. Those two top the list for underperforming sectors through September 27, 2017, compared with the same time last year. If you’re in Biotechnology, however, you’re not getting much sleep. We pulled data for the years 2016 and 2017, each set through September 27, just to see which sectors are up, and which are down. Overall, deal volume is 8% ahead of the same time last year, when the presidential election was raging. So far this year, we’ve recorded 1,105 transactions, compared with 1.024 in the same period in 2016. The... Read More »Health Care M&A Weekly Deals, The Week Ending September 22, 2017
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Mitobridge, Inc. License to NAD+ intellectual property N/A Pluriomics B.V. Axiogenesis AG N/A InDevR, Inc. License to monoclonal antibodies N/A STEMCELL Technologies Inc. License to EpiX™ technology N/A... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
